Bayer, One Drop release digital health program for heart disease

Screenshots of One Drop's app, showing blood pressure goals and trends. Screenshots of One Drop's app, showing blood pressure goals and trends.

One Drop and Bayer rolled out a digital health platform for cardiovascular disease prevention.

After striking a partnership last year, One Drop and Bayer are releasing their first digital health program for lowering the risk of heart disease. To start, One Drop plans to offer it to employers through its multi-condition program, but also plans to offer it to consumers through its app this year.

It pulls in data from connected devices to help people track their blood pressure, weight and other metrics. For example, One Drop has an integration with Withings, providing its connected blood pressure cuffs and scales to some of its members.

The program also includes food logging, educational modules, and coaching from registered nurses and dieticians. The goal is to help people at risk of heart disease and lower costs for employers and health plans.

New York-based One Drop started in 2015 as an app to help people with Type 1 and Type 2 diabetes track their metrics. Soon after, it began integrating devices, including glucometers and test strips.

That puts One Drop in competition with other digital health heavyweights, including Livongo and Omada. The company has built out a distribution network through Walmart, CVS, Amazon and Best Buy, and with its partnership with Bayer, it plans to expand into additional health conditions in the future.

“The life-altering potential of our cardiovascular disease prevention module would not have been possible without the support and deep expertise from our strategic partner, Bayer,” Rachel Yap Martens, One Drop’s executive vice president of commercial solutions and corporate strategy, said in a news release. “The CVD prevention module is one of many outputs to come, thanks to our productive partnership that will help countless people improve their lives.”

Bayer led a $34.7 million funding round in the company last year, and also agreed to pay One Drop up to $64 million in development fees and commercial milestone payments. In addition to cardiology, they also plan to build solutions for oncology and women’s health.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *